Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Jun 16;29(2):e52-e60.
doi: 10.47750/jptcp.2022.931. eCollection 2022.

Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy

Ghadah Ali Al-Oudah  1   2 , Ahmed Salih Sahib  3 , Mohammed K Al-Hattab  4 , Ali Ameer Al-Ameedee  5
Affiliations
Clinical Trial

Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy

Ghadah Ali Al-Oudah et al. J Popul Ther Clin Pharmacol. .

Abstract

Psoriasis is a medical condition in which the skin of the body is affected at a multisytemic level. Patients with moderate to severe psoriasis have a considerably reduced quality of life as a result of their disease. For morphological indicators, the Psoriasis Area Severity Index (PASI) test is one of the methods for indicating the severity of the illness. An imbalance between pro-oxidants and antioxidants in our bodies causes oxidative stress and plays a crucial role in the pathophysiology of chronic inflammatory diseases like psoriasis(1). It has been considered that antioxidant treatment can be an effective therapeutic option. The goal of this clinical investigation was to see if there was a link between the percentage change in quality of life and the clinical severity of psoriasis during a 12-week period among Iraqi psoriatic patients. Over the course of 3 months, 24 psoriatic patients (9 females and 15 males) ranging in age from 17 to 72 years participated in a prospective double-blinded clinical experiment. Two groups of participants were formed. A biological medicine (adalimumab) and a placebo was given to group A (n = 11), whereas group B (n = 13) received 100 mg CoQ10 adjuvant therapy in addition to the biological medication already provided. The Psoriasis Area and Severity Index (PASI) and the Dermatology Life Quality Index (DLQI) were used to examine patients (DLQI). Treatment with both biological and adjuvant CoQ10 therapy showed a substantial association between the PASI and the DLQI (p = 0.000132). After 3 months of therapy, the mean (SD) of the PASI score for all patients was 20.88 7.15, with a 67.48% ± 22.25% improvement change. The mean SD of the DLQI score at baseline was 12.5 ± 4.71, with a change of 56.13% ± 20.15% following treatment. After therapy with a biological medication, there was a favorable association between the PASI and the DLQI (p > 0.05). This indicates that therapy with a biological medication with daily administration of 100 mg CoQ10 supplements to psoriatic patients for 12 weeks improved the correlation between PASI and DLQI.

Keywords: Biological therapy; CoQ10; DLQI; PASI; psoriasis.

PubMed Disclaimer

Conflict of interest statement

The authors of the study do not have any conflicts of interest

References

    1. 1. Guarneri F, Bertino L, Pioggia G, et al. Therapies with antioxidant potential in Psoriasis, Vitiligo, and Lichen Planus. Antioxidants. 2021;10:1087. 10.3390/antiox10071087 - DOI
    1. 2. Lima et al.. Psoriasis prevalence among the 2009 AAD National,Melanoma/Skin Cancer Screening Program participants. J Eur Acad Dermatol Venereol. 2013;27:680–685. 10.1111/j.1468-3083.2012.04531.x - DOI
    1. 3. Griffiths CE, Christophers E, Barker JN, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156(2):258–262. 10.1111/j.1365-2133.2006.07675.x - DOI
    1. 4. Al-Sultany et al. A-Sea. Assessment of serum zinc, copper and copper/zinc ratio in adult patients with psoriasis. Ann Trop Med Public Health. 2020; 23:27–38. 10.36295/ASRO.2020.2315 - DOI
    1. 5. Timotijević S, et al. The impact of changes in psoriasis area and, severity index by body region on quality of life, in patients with psoriasis. Acta Dermatovenerol Croat. 2017;25(3):215–222.

Publication types

LinkOut - more resources